I was reading something a few days ago about if ARWR has good results it maybe a good buyout for GILD. I know the Hep B market is bigger than the Hep C.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.